ATLANTA, December 09, 2025--(BUSINESS WIRE)--Nephrodite Inc., a medical device company developing an implantable, continuous dialysis system, today announced successful results from a multi-day large ...

Holly™ by Nephrodite becomes the first device to achieve the designation, marking a major regulatory milestone toward first-in-human clinical studies ATLANTA, December 15, 2025--(BUSINESS ...

Please provide your email address to receive an email when new articles are posted on . “Dialysis is a relatively high-cost treatment, with previous commentators estimating that the U.K. [National ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted marketing authorization to Medtronic Inc. for a new device designed to provide continuous ...

Researchers at the Mayo Clinic, in Rochester, Minnesota, report what they say is the first study to examine correlates of successful liberation from continuous renal replacement therapy (CRRT) in a ...

For the second time in her life, Venis Gibby is the recipient of a gift she hoped she would never need. After years of doctor's appointments, emergency room visits and continuous dialysis, Gibby, 39, ...

Community Hospital South leaders faced an unexpected, and urgent, dilemma. Like many other health care facilities, the hospital works with another company to provide dialysis care to its patients. So ...

In what is believed to be the first study of its kind, new UVA Health research reveals that a factory-calibrated continuous glucose monitor (CGM) may be sufficiently accurate for use by people on ...

Nephrodite Inc., a medical device company developing an implantable, continuous dialysis system, today announced successful results from a multi-day large animal study of its Holly(TM) implantable ...

The Holly™ by Nephrodite device demonstrated continuous kidney function replacement in a large animal marking a critical milestone toward commercialization Nephrodite Inc., a medical device company ...